Supreme Court granted a stay permitting mifepristone to continue being dispensed by mail while the legal challenge proceeds.
The stay blocks a May 1, 2026 Fifth Circuit order that would have reinstated an in‑person dispensing requirement.
Manufacturers Danco Laboratories and GenBioPro Inc. won the request; Louisiana is challenging the FDA’s remote‑prescription rule.
Justices Clarence Thomas and Samuel Alito dissented, labeling the manufacturers a criminal enterprise and citing Dobbs.